**Core Concept**
The underlying principle being tested is the concept of **microdosing** in pharmacology, which involves administering very small doses of a drug to assess its **pharmacokinetics** and **pharmacodynamics**. This approach is used to evaluate the safety and efficacy of new drugs. Microdosing helps in identifying potential **adverse effects** at an early stage.

**Why the Correct Answer is Right**
Although the options are missing, typically, microdoses of a drug are tested on **humans** to assess acute adverse effects. This is because human microdosing studies allow for the direct evaluation of a drug's effects in the target species, providing valuable information on its safety profile. The **Food and Drug Administration (FDA)** and other regulatory agencies support microdosing studies as a means to streamline the drug development process.

**Why Each Wrong Option is Incorrect**
**Option A:**
**Option B:**
**Option C:**
**Option D:**

Since the options are not provided, it's not possible to give specific reasons for their incorrectness. However, in general, testing microdoses on animals or in vitro systems may not accurately predict human adverse effects due to **species differences** in drug metabolism and response.

**Clinical Pearl / High-Yield Fact**
Microdosing is a crucial step in the drug development process, enabling the identification of potential **toxicities** and **side effects** early on. This approach can help reduce the risk of adverse reactions in patients and streamline the development of safe and effective therapies.

**Correct Answer:** Not provided due to missing options.